Haitham Elbardisi

Haitham Elbardisi

Auto-generated profile, based on publicly available information

Haitham Elbardisi

Hamad Medical Corporation

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
NPNeel Parekh
Neel Parekh
MSManesh Kumar Panner Selvam
Manesh Kumar Panner Selvam
Ralf HenkelRalf Henkel
Ralf Henkel
RSRupin Shah
Rupin Shah
AHAvi Harlev
Avi Harlev
Agarwal A, et al. World J Mens Health. 2019 Sep;37(3):296-312. https://doi.org/10.5534/wjmh.190055

1 November 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
KFKhalid A. Fakhro
Khalid A. Fakhro
HEHaitham Elbardisi
Haitham Elbardisi
MAMohamed Arafa
Mohamed Arafa
ARAmal Robay
Amal Robay
JRJuan L. Rodriguez-Flores
Juan L. Rodriguez-Flores
SSSami Al Said
Sami Al Said

1 November 2016 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
HBHaitham El Bardisi
Haitham El Bardisi
AMAhmad Majzoub
Ahmad Majzoub
MAMohamed Arafa
Mohamed Arafa
AAAhmad AlMalki
Ahmad AlMalki
SSSami Al Said
Sami Al Said
ESEdmund Sabanegh
Edmund Sabanegh

6 March 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
MAMohamed Arafa
Mohamed Arafa
Ashok AgarwalAshok Agarwal
Ashok Agarwal
AMAhmad Majzoub
Ahmad Majzoub
MSManesh Kumar Panner Selvam
Manesh Kumar Panner Selvam
SBSaradha Baskaran
Saradha Baskaran
HEHaitham Elbardisi
Haitham Elbardisi
Antioxidants are used in the empirical treatment of infertile men. The aim of this study was to evaluate the effects of antioxidant therapy on conventional semen parameters and advanced sperm function tests in men seeking fertility treatment. A total of 148 infertile men of unknown etiology were divided into idiopathic (n = 119) and unexplained male infertility (UMI; n = 29). All participants were treated with the antioxidant supplement ‘FH PRO for Men’ for a period of three months. Compared with pretreatment results, there was a significant improvement in conventional semen parameters including sperm concentration, total and progressive motility and normal morphology, and seminal oxidation reduction potential (ORP), and sperm DNA fragmentation (SDF) in idiopathic infertile men. The changes were more prominent in idiopathic infertile men positive for ORP and SDF. UMI patients showed an improvement in progressive motility, ORP, and SDF after antioxidant treatment. Statistical analysis revealed that the efficacy of FH PRO for Men was significant in idiopathic male infertility compared with UMI. Treatment of idiopathic male infertility patients with the FH PRO for Men antioxidant regimen for three months resulted in a significant improvement in conventional semen parameters and sperm function. Therefore, FH PRO for Men offers promise for the medical treatment of idiopathic male infertility.

1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
Rossella CannarellaRossella Cannarella
Rossella Cannarella
Ramadan SalehRamadan Saleh
Ramadan Saleh
FBFlorence Boitrelle
Florence Boitrelle
MGMurat Gul
Murat Gul
RSRupin Shah
Rupin Shah
Agarwal A, et al. World J Mens Health. 2022 Oct;40:e70. https://doi.org/10.5534/wjmh.220142

1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
RSRupin Shah
Rupin Shah
Ashok AgarwalAshok Agarwal
Ashok Agarwal
PKParviz Kavoussi
Parviz Kavoussi
ARAmarnath Rambhatla
Amarnath Rambhatla
Ramadan SalehRamadan Saleh
Ramadan Saleh
Giovanni Maria ColpiGiovanni Maria Colpi
Giovanni Maria Colpi
Shah R, et al. World J Mens Health. 2023 Jan;41(1):164-197. https://doi.org/10.5534/wjmh.220048